The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages

BMC Microbiology

Volumn 6, Issue , 2006, Pages

  Mosser, Elise M ^a   Rest, Richard F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CHOLESTEROL; CYTOLYSIN; LACTATE DEHYDROGENASE; PHOSPHOLIPASE; POLYGLUTAMIC ACID; PROTEIN ANTROLYSIN O; PROTEINASE; RECOMBINANT PROTEIN; TRYPAN BLUE; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BACILLUS ANTHRACIS; BACTERIAL STRAIN; BLOOD LEVEL; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; LETHALITY; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; TIMED DRUG RELEASE;

BACILLUS ANTHRACIS; BACTERIAL PROTEINS; CELL LINE; CHOLESTEROL; CYTOTOXINS; EPITHELIAL CELLS; HUMANS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MONOCYTES; NEUTROPHILS; RECOMBINANT PROTEINS; TRYPAN BLUE;

ANIMALIA; BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 33747422885     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-6-56     Document Type: Article

References (40)

1. Dixon TC, Meselson M, Guillemin J, Hanna PC: Anthrax. N Engl J Med 1999, 341(11):815-826.
2. Hanna P: Anthrax pathogenesis and host response. Curr Top Microbiol Immunol 1998, 225:13-35.
3. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer M, Greene C, Griffith KS, Guarner J, Hadler JL, Hayslett JA, Meyer R, Petersen LR, Phillips M, Pinner R, Popovic T, Quinn CP, Reefhuis J, Reissman D, Rosenstein N, Schuchat A, Shieh WJ, Siegal L, Swerdlow DL, Tenover FC, Traeger M, Ward JW, Weisfuse I, Wiersma S, Yeskey K, Zaki S, Ashford DA, Perkins BA, Ostroff S, Hughes J, Fleming D, Koplan JP, Gerberding JL, National Anthrax Epidemiologic Investigation Team: Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002, 8(10):1019-1028.
4. Brossier F, Mock M: Toxins of Bacillus anthracis. Toxicon 2001, 39(11):1747-1755.
5. Okinaka RT, Cloud K, Hampton O, Hoffmaster AR, Hill KK, Keim P, Koehler TM, Lamke G, Kumano S, Mahillon J, Manter D, Martinez Y, Ricke D, Svensson R, Jackson PJ: Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol 1999, 181(20):6509-6515.
6. Dixon TC, Fadl AA, Koehler TM, Swanson JA, Hanna PC: Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape. Cell Microbiol 2000, 2(6):453-463.
7. Mock M, Fouet A: Anthrax. Annu Rev Microbiol 2001, 55:647-671.
8. Shannon JG, Ross CL, Koehler TM, Rest RF: Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin. Infect Immun 2003, 71(6):3183-3189.
9. Klichko VI, Miller J, Wu A, Popov SG, Alibek K: Anaerobic induction of Bacillus anthracis hemolytic activity. Biochem Biophys Res Commun 2003, 303(3):855-862.
10. Popova TG, Millis B, Bradburne C, Nazarenko S, Bailey C, Chandhoke V, Popov SG: Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors. BMC Microbiol 2006, 6:8.
11. Giddings KS, Zhao J, Sims PJ, Tweten RK: Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol 2004, 11(12):1173-1178.
12. Madden JC, Ruiz N, Caparon M: Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria. Cell 2001, 104(1):143-152.
13. Polekhina G, Giddings KS, Tweten RK, Parker MW: Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc Natl Acad Sci USA 2005, 102(3):600-605.
14. Alouf JE: Cholesterol-binding cytolytic protein toxins. Int J Med Microbiol 2000, 290(4-5):351-356.
15. Bielecki J, Youngman P, Connelly P, Portnoy DA: Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 1990, 345(6271):175-176.
16. Billington SJ, Jost BH, Songer JG: Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiol Lett 2000, 182(2):197-205.
17. Goebel W, Kreft J: Cytolysins and the intracellular life of bacteria. Trends Microbiol 1997, 5(3):86-88.
18. Segura M, Gottschalk M: Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity. Infect Immun 2002, 70(8):4312-4322.
19. Jost BH, Songer JG, Billington SJ: An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence. Infect Immun 1999, 67(4):1723-1728.
20. O'Brien DK, Melville SB: Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun 2004, 72(9):5204-5215.
21. Sierig G, Cywes C, Wessels MR, Ashbaugh CD: Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun 2003, 71(1):446-455.
22. Tanigawa T, Suzuki J, Ueta T, Katsumoto T, Tanaka Y: Different sensitivity to streptolysin-O of cells in macrophage lineage. Microbiol Immunol 1996, 40(1):81-84.
23. Andersen BR, Van Epps DE: Suppression of chemotatic activity of human neutrophils by streptolysin O. J Infect Dis 1972, 125(4):353-359.
24. Cockeran R, Steel HC, Mitchell TJ, Feldman C, Anderson R: Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect Immun 2001, 69(5):3494-3496.
25. Johnson MK, Boese-Marrazzo D, Pierce WA Jr: Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect Immun 1981, 34(1):171-176.
26. Paton JC, Ferrante A: Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun 1983, 41(3):1212-1216.
27. Paton JC, Rowan-Kelly B, Ferrante A: Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 1984, 43(3):1085-1087.
28. Srivastava A, Henneke P, Visintin A, Morse SC, Martin V, Watkins C, Paton JC, Wessels MR, Golenbock DT, Malley R: The apoptotic response to pneumolysin is toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun 2005, 73:6479-6487.
29. Park JM, Ng VH, Maeda S, Rest RF, Karin M: Anthrolysin O and other gram- positive cytolysins are toll-like receptor 4 agonists. J Exp Med 2004, 200(12):1647-1655.
30. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT: Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003, 100(4):1966-1971.
31. Portnoy DA, Tweten RK, Kehoe M, Bielecki J: Capacity of listeriolysin O, streptolysin O, and perfringolysin O to mediate growth of Bacillus subtilis within mammalian cells. Infect Immun 1992, 60(7):2710-2717.
32. Palmer M: Cholesterol and the activity of bacterial toxins. FEMS Microbiol Lett 2004, 238(2):281-289.
33. Cocklin S, Jost M, Robertson NM, Weeks SD, Weber HW, Young E, Seal S, Zhang C, Mosser E, Loll PJ, Saunders A J, Rest RF, Chaiken IM: Real-time monitoring of the membrane-binding and insertion properties of the cholesterol-dependent cytolysin anthrolysin O from Bacillus anthracis. J Molec Recognition 2006 in press.
34. Hirst RA, Yesilkaya H, Clitheroe E, Rutman A, Dufty N, Mitchell TJ, O'Callaghan C, Andrew PW: Sensitivities of human monocytes and epithelial cells to pneumolysin are different. Infect Immun 2002, 70(2):1017-1022.
35. Lyons CR, Lovchik J, Hutt J, Lipscomb MF, Wang E, Heninger S, Berliba L, Garrison K: Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect Immun 2004, 72(8):4801-4809.
36. Wei Z, Schnupf P, Poussin MA, Zenewicz LA, Shen H, Goldfine H: Characterization of Listeria monocytogenes expressing anthrolysin O and phosphatidylinositol-specific phospholipase C from Bacillus anthracis. Infect Immun 2005, 73(10):6639-6646.
37. Cataldi A, Labruyere E, Mock M: Construction and characterization of a protective antigen-deficient Bacillus anthracis strain. Mol Microbiol 1990, 4(7):1111-1117.
38. Rest RF, Speert DP: Measurement of nonopsonic phagocytic killing by human and mouse phagocytes. Methods Enzymol 1994, 236:91-108.
39. Roth P, Stanley ER: The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol 1992, 181:141-167.
40. Cathelin S, Rebe C, Haddaoui L, Simioni N, Verdier F, Fontenay M, Launay S, Mayeux P, Solary E: Identification of proteins cleaved downstream of caspase activation in monocytes undergoing macrophage differentiation. J Biol Chem 2006.